![Raymond J. Hohl](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Raymond J. Hohl
Nessuna posizione attualmente
Profilo
Raymond J.
Hohl was the founder of Terpenoid Therapeutics, Inc. founded in 2005, where he held the title of President from 2005 to 2012.
He was a former Professor of Internal Medicine & Pharmacology at the University of Iowa.
He also held the position of Principal at The American Society for Clinical Pharmacology & Therapeutics in 2006 and at The Holden Comprehensive Cancer Center in 2005.
Dr. Hohl received his doctorate from Rush University and his undergraduate degree from the University of Illinois.
Precedenti posizioni note di Raymond J. Hohl
Società | Posizione | Fine |
---|---|---|
The American Society for Clinical Pharmacology & Therapeutics
![]() The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Corporate Officer/Principal | 01/01/2006 |
The Holden Comprehensive Cancer Center | Corporate Officer/Principal | 01/01/2005 |
University of Iowa | Corporate Officer/Principal | - |
Terpenoid Therapeutics, Inc.
![]() Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Fondatore | - |
Formazione di Raymond J. Hohl
University of Illinois | Undergraduate Degree |
Rush University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Terpenoid Therapeutics, Inc.
![]() Terpenoid Therapeutics, Inc. Medical DistributorsDistribution Services Terpenoid Therapeutics, Inc. operates as a biotechnology company focuses on anti-cancer therapeutics. The firm engages in creating, testing, and developing novel drug candidates using cutting-edge technologies. It is focused on discovering small molecule inhibitors of geranylgeranyl diphosphate synthase, a novel target with applicability towards cancer and other indication. The company was founded by Andrew J. Wiemer, Jeffery D. Neighbors, David F. Wiemer and Raymond J. Hohl in September 2005 and is headquartered in Coralville, IA. | Distribution Services |
The Holden Comprehensive Cancer Center | |
The American Society for Clinical Pharmacology & Therapeutics
![]() The American Society for Clinical Pharmacology & Therapeutics Miscellaneous Commercial ServicesCommercial Services The American Society for Clinical Pharmacology & Therapeutics is a scientific and professional organization that serves the disciplines of clinical pharmacology and translational medicine. The non-profit company is based in Alexandria, VA. The CEO of the company is Sharon Swan. | Commercial Services |
- Borsa valori
- Insiders
- Raymond J. Hohl